「fo」の検索結果
123件：116～120件目を表示
-
お知らせ | 千寿製薬株式会社
ough TRPV1 Inhibition（PDF） December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Rece...
http://www.senju.co.jp/english/news/ -
Milestones in Our History | About Senju | SENJU Pharmaceutical
ished the company in Tennoji-ku, Osaka with start-up capital of 195,000 yen. July Injection Product for Neutropenia, "PANILTIN", sales launched 1949 February Reishin Tanimura became the Pres...
https://www.senju.co.jp/english/about/history.html -
Product Development Policy | Research & Development | SENJU Pharmaceutica
ehold” or QOV (Quality of Vision) of patients worldwide. We launched senile cataract drugs in 1958, followed by a series of other products including antimicrobial ophthalmic solutions, non-steroidal a...
http://www.senju.co.jp/english/rd/policy/ -
Research and Development System | Research & Development | SENJU Pharmaceutica
All things in nature have a reason for being.Today’s common sense may not be common sense tomorrow. At Senju Pharmaceutical, we are dedicated not only to our original R&D initiatives but also to R...
http://www.senju.co.jp/english/rd/about/ -
Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
Communications with Customers and Provision of Information to Senju Pharmaceutical has a Customer Service Center for directly responding to inquiries from consumers and patients. The role of the Cente...
https://www.senju.co.jp/english/about/csr01.html